Kessler Topaz Meltzer & Check, LLP is currently investigating potential violations of the federal securities laws on behalf of purhasers of AdaptHealth Corp. (“AdaptHealth”) (NASDAQ: AHCO) securities between November 4, 2020 and July 18, 2021.
AdaptHealth investors may receive additional information about the investigation by clicking the link "Submit Your Information" above.
On July 19, 2021, Jehoshaphat Research published a short report on AdaptHealth claiming that the company “a roll-up of roll-ups with excessive debt, is deceiving the investor community via its financial reporting practices.”
The report further stated that “while management claims (and consensus estimates reflect) an organic growth trajectory of 8-10%, AHCO is in fact experiencing double-digit organic decline. It is also, in our opinion, taking steps to obscure that decline which are expressly forbidden by the SEC.”
AdaptHealth’s stock price fell after publication of this report.
If you have any questions or would like to discuss this investigation, please contact Kessler Topaz Meltzer & Check, LLP: James Maro, Esq. (484) 270-1453; toll-free at (844) 887-9500; or via e-mail at firstname.lastname@example.org.